Early research (Phase 1)Study completedNCT00002765What this trial is testingImmunotoxin in Treating Patients With Leukemia or LymphomaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01838434What this trial is testingLenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaWho this might be right forRelapsed/Refractory Mantle Cell Lymphoma Alliance for Clinical Trials in Oncology 106
Early research (Phase 1)Study completedNCT02142530What this trial is testingCarfilzomib Plus Belinostat in Relapsed/Refractory NHLWho this might be right forNon-Hodgkin LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma+2 more Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Study completedNCT00028665What this trial is testingCyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's LymphomaWho this might be right forLymphoma Case Comprehensive Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00003245What this trial is testingIrinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT03523975What this trial is testingVenetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma City of Hope Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT01686165What this trial is testingBelinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHLWho this might be right forAnaplastic Large Cell LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma University of Arizona 5
Large-scale testing (Phase 3)Study completedNCT00053053What this trial is testingComparison of Nutritional Supplements in Preventing Weight Loss in Patients With CancerWho this might be right forCachexiaLymphomaLymphoproliferative Disorder+1 more Radiation Therapy Oncology Group 472
Testing effectiveness (Phase 2)Ended earlyNCT00383565What this trial is testingFR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00002663What this trial is testingBiological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or MalignanciesWho this might be right forEBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma Atara Biotherapeutics 58
Early research (Phase 1)Study completedNCT00006362What this trial is testingPS-341 in Treating Patients With Advanced CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00782379What this trial is testingCombination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Northside Hospital, Inc. 20
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00151320What this trial is testingPhase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHLWho this might be right forNon-Hodgkin's Lymphoma Weill Medical College of Cornell University 76
Early research (Phase 1)Study completedNCT00561418What this trial is testingVorinostat After Stem Cell Transplant in Treating Patients With High-Risk LymphomaWho this might be right forLymphomaSmall Intestine Cancer Ohio State University Comprehensive Cancer Center 23
Early research (Phase 1)Active Not RecruitingNCT02717624What this trial is testingAcalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCLWho this might be right forMantle Cell Lymphoma (MCL) Acerta Pharma BV 72
Testing effectiveness (Phase 2)WithdrawnNCT02281279What this trial is testingRituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueIntraocular Lymphoma+20 more Mayo Clinic
Very early researchStudy completedNCT00424242What this trial is testingPemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Northwestern University 15
Testing effectiveness (Phase 2)Study completedNCT00003397What this trial is testingPeripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Maryland, Baltimore 25
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center